We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
+10.08%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$644M
AUM Growth
+$39.6M
Cap. Flow
+$5.56M
Cap. Flow %
0.86%
Top 10 Hldgs %
35.41%
Holding
200
New
77
Increased
40
Reduced
23
Closed
50

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$14.2M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$12.7M
3
CELG
Celgene Corp
CELG
+$12.4M
4
PEGI
Pattern Energy Group Inc. Class A
PEGI
+$8.27M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$7.96M

Top Sells

Rank Stock Value
1
NRF
NorthStar Realty Finance Corp.
NRF
+$15M
2
AKRX
Akorn Inc
AKRX
+$12.7M
3
SUM
Summit Materials, Inc. Class A Common Stock
SUM
+$9.32M
4
GLBL
TerraForm Global, Inc. Class A Common Stock
GLBL
+$7.95M
5
MRT
MedEquities Realty Trust, Inc.
MRT
+$7.26M

Sector Composition

Rank Sector Weight
1 Healthcare 13.08%
2 Technology 10.1%
3 Financials 8.58%
4 Energy 7.12%
5 Real Estate 6.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GWPH
101
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$484K 0.08%
+4,001
New +$491K
CSC
102
DELISTED
Computer Sciences
CSC
$483K 0.08%
+7,000
New +$464K
TEVA icon
103
Teva Pharmaceuticals
TEVA
$41.2B
$481K 0.07%
+15,000
New +$512K
INCY icon
104
Incyte
INCY
$24.9B
$468K 0.07%
3,500
– –
OXFD
105
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$465K 0.07%
30,000
– –
P
106
Everpure Inc
P
$25B
$442K 0.07%
45,000
+25,500
+131% +$282K
RHT
107
DELISTED
Red Hat Inc
RHT
$433K 0.07%
+5,000
New +$397K
BABA icon
108
Alibaba
BABA
$279B
$431K 0.07%
+4,000
New +$407K
AQMS icon
109
Aqua Metals
AQMS
$10.2M
$420K 0.07%
+108
New +$336K
CTXS
110
DELISTED
Citrix Systems Inc
CTXS
$417K 0.06%
+5,000
New +$390K
SMTC icon
111
Semtech
SMTC
$10.7B
$406K 0.06%
+12,000
New +$403K
CAR icon
112
PUT
Avis
CAR
$5.37B
$370K 0.06%
+12,500
New +$434K
ATRC icon
113
AtriCure
ATRC
$2.04B
$364K 0.06%
+19,000
New +$333K
INTU icon
114
Intuit
INTU
$86.3B
$348K 0.05%
3,000
-2,000
-40% -$240K
HZNP
115
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$347K 0.05%
+23,500
New +$381K
JKS
116
JinkoSolar
JKS
$777M
$331K 0.05%
+20,000
New +$317K
AMGN icon
117
Amgen
AMGN
$209B
$328K 0.05%
+2,000
New +$332K
PRTK
118
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$308K 0.05%
16,000
+3,500
+28% +$55.1K
OUT icon
119
Outfront Media
OUT
$5.62B
$284K 0.04%
10,871
– –
CCJ icon
120
Cameco
CCJ
$38.4B
$277K 0.04%
+25,000
New +$285K
OUT icon
121
PUT
Outfront Media
OUT
$5.62B
$266K 0.04%
+10,160
New +$266K
PTC icon
122
PTC
PTC
$15.7B
$263K 0.04%
+5,000
New +$264K
ADMS
123
DELISTED
Adamas Pharmaceuticals
ADMS
$263K 0.04%
15,000
– –
BIDU icon
124
CALL
Baidu
BIDU
$36.5B
$259K 0.04%
+1,500
New +$264K
WAAS
125
DELISTED
AquaVenture Holdings Limited
WAAS
$256K 0.04%
+15,000
New +$272K
3 4
5
6 7

Similar funds

NA
Navellier & Associates Reno, Nevada $960M AUM 79.37% 1-Year Est. Return
MK
MASTERINVEST Kapitalanlage Vienna $962M AUM 27.59% 1-Year Est. Return
QIM
Quantitative Investment Management Charlottesville, Virginia $963M AUM 12.95% 1-Year Est. Return
JVBC
J.V. Bruni & Co Colorado Springs, Colorado $958M AUM 22.2% 1-Year Est. Return
TFP
Triple Frond Partners San Francisco, California $963M AUM 27.45% 1-Year Est. Return
UWPG
Ullmann Wealth Partners Group Jacksonville Beach, Florida $963M AUM 17.06% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Ardsley Advisory Partners's Q1 2017 Portfolio in Review

As of Q1 2017, Ardsley Advisory Partners held 200 positions worth $644M, up 6.6% from $604M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Ardsley Advisory Partners's Q1 2017 filing shows 77 new, 40 increased, 23 reduced and 50 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 89,500 shares worth $7.86M. The largest sale was NorthStar Realty Finance Corp., an estimated $15M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 7.3% a quarter earlier, followed by Technology and Financials.

  • Ardsley Advisory Partners's largest Q1 2017 buy was BioMarin Pharmaceuticals: 89,500 shares worth $7.86M.
  • Ardsley Advisory Partners added most to State Street SPDR S&P Biotech ETF in Q1 2017, an estimated $14.2M increase.
  • Ardsley Advisory Partners's biggest Q1 2017 reduction was Akorn Inc, cutting an estimated $12.7M.
  • Ardsley Advisory Partners fully exited NorthStar Realty Finance Corp. in Q1 2017, selling an estimated $15M.
  • Ardsley Advisory Partners's ten largest holdings make up 35% of its $644M portfolio in Q1 2017.
  • Ardsley Advisory Partners opened 77 new positions and closed 50 in Q1 2017.
  • Ardsley Advisory Partners's portfolio value rose 6.6% quarter-over-quarter to $644M.

Based on Ardsley Advisory Partners's 13F filing for Q1 2017, filed 15 May 2017.